SCHEMBL208706

SCHEMBL208706

Cc1ccc(S(=O)(=O)OC2CCN(OC(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.57
CYP1A2 P05177 1/20 0.43
MMP13 P45452 1/20 0.39
GPR119 Q8TDV5 6/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
STS P08842 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27927598 0.89 CYP2D6 (0.61) CYP2D6CYP1A2MMP13GPR119CYP3A4
SCHEMBL184777 0.83 CYP2D6 (0.60) CYP2D6MMP13GPR119KMT2AMEN1
SCHEMBL28126238 0.82 CYP2D6 (0.55) CYP2D6CYP1A2MMP13CYP3A4CYP2C19
SCHEMBL28719877 0.79 CYP2D6 (0.55) CYP2D6MMP13GPR119KMT2AMEN1
SCHEMBL5447212 0.79 CYP2D6 (0.55) CYP2D6MMP13GPR119KMT2AMEN1
SCHEMBL19001727 0.79 CYP2D6 (0.55) CYP2D6MMP13GPR119KMT2AMEN1
SCHEMBL222877 0.79 CYP2D6 (0.54) CYP2D6CYP1A2MMP13GPR119KMT2A
SCHEMBL221064 0.79 CYP2D6 (0.54) CYP2D6CYP1A2MMP13GPR119KMT2A
SCHEMBL221063 0.79 CYP2D6 (0.54) CYP2D6CYP1A2MMP13GPR119KMT2A
SCHEMBL21340275 0.78 CYP2D6 (0.51) CYP2D6CYP1A2MMP13GPR119CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2400962-B1 Medicinal combinations containing PDE4 inhibitors and NSAIDS BOEHRINGER INGELHEIM INT (DE) 2017-11-08 EP disclosed
EP-2555774-B1 Medicine combinations containing pde4 inhibitors and ep4 receptor antagonists BOEHRINGER INGELHEIM INT (DE) 2015-10-21 EP disclosed
EP-2610258-B1 Substituted piperidino dihydrothieno pyrimidines BOEHRINGER INGELHEIM INT (DE) 2014-08-27 EP disclosed
EP-2380891-B1 Substituted piperidino-dihydrothienopyrimidines BOEHRINGER INGELHEIM INT (DE) 2013-12-11 EP disclosed
EP-2610258-A1 Substituted piperidino dihydrothieno pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-07-03 EP disclosed
EP-2215092-B1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INT (DE) 2012-01-25 EP disclosed
EP-2400962-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
EP-2380891-A1 Substituted piperidino-dihydrothienopyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-26 EP disclosed
WO-2010097334-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
EP-2215092-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES Boehringer Ingelheim International GmbH (DE) 2010-08-11 EP disclosed
WO-2009050248-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed